[Use of protein metabolism activators in combined therapy of chronic iron-deficiency anemia].
D000328:Adult; D000596:Amino Acids / Q000627:therapeutic use*; D000747:Anemia, Hypochromic / Q000097:blood / Q000188:drug therapy*; D001711:Biotransformation / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism*; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007501:Iron / Q000097:blood / Q000627:therapeutic use; D008875:Middle Aged; D009963:Orotic Acid / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use
D000596:Amino Acids; D001798:Blood Proteins; D014815:Vitamins; C046979:alvesin; D009963:Orotic Acid; D007501:Iron
Primenenie aktivatorov belkovogo obmena v kompleksnoĭ terapii khronicheskikh zhelezodefitsitnykh anemiĭ.